Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SKABUP: 10% vs 5% Permethrin Cream for Scabies
NCT06380452Phase 3Not yet recruiting
- Sponsor
- InfectoPharm
- Start
- May 2024
- Primary completion
- Jul 2027
- Modality
- Allosteric Modulators
01
Overview
Phase 3, randomised, double-blind trial of permethrin in scabies (2 arms), sponsored by InfectoPharm. Primary endpoint: Clinical Efficacy (Therapeutic Success) at Day 28. Planned start May 2024; status: not yet recruiting.
02
Drugs
permethrin
03
Conditions
scabies
Beyond the preview
Go deeper on NCT06380452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06380452.